Delivery of a STING Agonist Using Lipid Nanoparticles Inhibits Pancreatic Cancer Growth is a research paper published in International Journal of Nanomedicine (2024). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: R01 GM121798
NCI NIH HHS
Grant: R01 CA231099
NCI NIH HHS
Grant: R01 CA271592
National Institutes of Health
Grant: 5R01CA231099-04
Development of a targeted delivery platform for checkpoint inhibitors
National Institutes of Health
Grant: 5R01CA271592-02
Normalizing PDAC stroma with PCBP2 siRNA nanoparticles to improve the antitumor activity of chemotherapy and immunotherapy
National Institutes of Health
Grant: 5R01GM121798-04
Peptide-based conjugate for a water-insoluble drug treating advanced prostate cancer
FWCI
2.71
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals